Dr. Kevin Williams Issues Caution to African Americans About Rare Heart Disease
May 27, 2021
With the most recent collaboration between Pfizer Rare Disease and the Black Press, the organizations embarked on a mission to educate and raise awareness to transthyretin amyloid cardiomyopathy – or ATTR-CM. “ATTR-CM is a rare, life-threatening, underrecognized, and underdiagnosed type of amyloidosis that affects the heart and it is associated with heart failure,” Dr. Kevin Williams, Pfizer’s chief medical officer, told the NNPA in a live interview.